Skip to main content
Erschienen in: International Ophthalmology 10/2020

05.06.2020 | Original Paper

Effects of topical administration of tafluprost and combination of tafluprost and timolol or tafluprost and betaxolol on Schirmer tear test, intraocular pressure, and pupil size in clinically healthy dogs

verfasst von: Armin Shokoohimand, Farnoosh Arfaee, Ahmad Asghari, Ehsan Khaksar

Erschienen in: International Ophthalmology | Ausgabe 10/2020

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The aim of this study was to evaluate the effects of 0.0015% preservative-free (PF) tafluprost alone and in combination with 0.5% timolol maleate or 0.5% betaxolol HCl on Schirmer tear test (STT), intraocular pressure (IOP), and pupil diameter (PD) in clinically normal dogs.

Methods

Twenty-one healthy adult castrated male cross-bred dogs were used in this study. Dogs were randomly divided into three groups. The first group received one drop of (PF) tafluprost (Taf), in a randomly selected eye. The second group received one drop of (PF) tafluprost plus one drop of timolol maleate (Taf-Tim), and the last group received one drop of (PF) tafluprost plus one drop of betaxolol HCl, (Taf-Bet). In all groups, the fellow eyes were served as control and received one drop of saline as a placebo. IOP, STT, and PD measurements were performed at the baseline and every 30 min for the first 2 h, every 2 h for the next 10 h, and at 24 h and 36 h post-instillation (PI).

Results

In all groups, significant differences in IOP values were observed between treated and untreated eyes (Taf: p < 0.001, Taf-Tim: p = 0.014, Taf-Bet: p = 0.008). The maximum reduction in mean IOP after unilateral administration of Taf, Taf-Tim, and Taf-Bet was 8.3 mmHg, 10.7 mmHg, and 13 mmHg, respectively. No significant differences in STT values were observed between treated and untreated eyes at any time points. In all groups, significant differences in PD values were observed between treated and untreated eyes in all time points except the baseline and 36 h post-drug instillation (p < 0.001).

Conclusions

Tafluprost alone or in combination with timolol and betaxolol was able to reduce intraocular pressure. The greatest effect of the drugs occurred 6 and 8 h PI. The present study revealed that the combination of tafluprost/betaxolol is more potent in decreasing IOP than tafluprost alone or a combination of tafluprost/timolol in healthy dogs.
Literatur
1.
Zurück zum Zitat Plummer CE, Regnier A, Gelatt KN (2013) The canine glaucomas. In: Gelatt KN, Gilger BC, Kern TJ (eds) Veterinary ophthalmology, 5th edn. Wiley, Ames, Iowa, pp 1050–1145 Plummer CE, Regnier A, Gelatt KN (2013) The canine glaucomas. In: Gelatt KN, Gilger BC, Kern TJ (eds) Veterinary ophthalmology, 5th edn. Wiley, Ames, Iowa, pp 1050–1145
3.
Zurück zum Zitat Featherstone HJ, Heinrich CL (2013) Ophthalmic examination and diagnostics. In: Gelatt KN, Gilger BC, Kern TJ (eds) Veterinary ophthalmology, 5th edn. Wiley, Ames, Iowa, pp 533–613 Featherstone HJ, Heinrich CL (2013) Ophthalmic examination and diagnostics. In: Gelatt KN, Gilger BC, Kern TJ (eds) Veterinary ophthalmology, 5th edn. Wiley, Ames, Iowa, pp 533–613
9.
Zurück zum Zitat Takagi Y, Osaki H, Yamashita T, Kai Y (2016) Prospective observational post-marketing study of tafluprost 0.0015%/timolol 0.5% combination ophthalmic solution for glaucoma and ocular hypertension: short-term efficacy and safety. Ophthalmol Ther 5(2):191–206CrossRef Takagi Y, Osaki H, Yamashita T, Kai Y (2016) Prospective observational post-marketing study of tafluprost 0.0015%/timolol 0.5% combination ophthalmic solution for glaucoma and ocular hypertension: short-term efficacy and safety. Ophthalmol Ther 5(2):191–206CrossRef
20.
21.
Zurück zum Zitat Selkghaffari MBS, Barghy MH (2010) Effect of topical 0.5% betaxolol administration on intraocular pressure in clinically normal dogs. Comp Clin Pathol 19(3):3 Selkghaffari MBS, Barghy MH (2010) Effect of topical 0.5% betaxolol administration on intraocular pressure in clinically normal dogs. Comp Clin Pathol 19(3):3
22.
Zurück zum Zitat Chi W, Li A, Wang S, Zhu X (2013) Efficacy of combined administration of 0.2% brimonidine and 0.5% betaxolol in treatment of primary open angle glaucoma and ocular hypertension. Eye Sci 28(4):190–194PubMed Chi W, Li A, Wang S, Zhu X (2013) Efficacy of combined administration of 0.2% brimonidine and 0.5% betaxolol in treatment of primary open angle glaucoma and ocular hypertension. Eye Sci 28(4):190–194PubMed
25.
Zurück zum Zitat Noecker R, Miller KV (2011) Benzalkonium chloride in glaucoma medications. Ocul Surf 9(3):159–162CrossRef Noecker R, Miller KV (2011) Benzalkonium chloride in glaucoma medications. Ocul Surf 9(3):159–162CrossRef
Metadaten
Titel
Effects of topical administration of tafluprost and combination of tafluprost and timolol or tafluprost and betaxolol on Schirmer tear test, intraocular pressure, and pupil size in clinically healthy dogs
verfasst von
Armin Shokoohimand
Farnoosh Arfaee
Ahmad Asghari
Ehsan Khaksar
Publikationsdatum
05.06.2020
Verlag
Springer Netherlands
Erschienen in
International Ophthalmology / Ausgabe 10/2020
Print ISSN: 0165-5701
Elektronische ISSN: 1573-2630
DOI
https://doi.org/10.1007/s10792-020-01439-9

Weitere Artikel der Ausgabe 10/2020

International Ophthalmology 10/2020 Zur Ausgabe

Neu im Fachgebiet Augenheilkunde

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.